Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
VivaVision Biotech Announces Positive Topline Results of VVN001 in the Phase 2 Clinical Study for the Treatment of Dry Eye Disease 2022-03-23 08:00
Fosun Pharma 2021 Annual Results Announcement: Accelerating the Globalization Comprehensively 2022-03-23 06:53
WuXi Biologics Achieved Record Growth and Profitability in 2021 2022-03-23 00:38
INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use 2022-03-23 00:00
Jacobio Announces Annual Results of 2021, R&D Investment Increases 83% 2022-03-22 22:50
NIBIOHN Identifies Tissue-specific Exosome Marker Candidates from Blood 2022-03-22 14:00
OBiO Technology Goes Public on Shanghai Stock Exchange Today 2022-03-22 13:00
INTERVAPOR®, THERMAL VAPOR TREATMENT SYSTEM, APPROVED FOR MARKETING IN CHINA 2022-03-22 10:34
Ascentage Pharma's MDM2-p53 Inhibitor Alrizomadlin (APG-115) Granted Rare Pediatric Disease Designation by the US FDA for the Treatment of Neuroblastoma 2022-03-22 09:15
Cali Biosciences Announces Successful Results in Phase IIb Study of Long-Acting Ropivacaine (CPL-01) for Non-Opioid Treatment of Post-Operative Pain 2022-03-22 00:00
Ascentage Pharma Announces 2021 Annual Results with Commercialization Programs Going Full Steam Ahead 2022-03-21 23:11
BIOKANGTAI Signs a Cooperation Agreement with the Largest Importer of Parenteral Products in Philippines 2022-03-21 22:22
3billion to reveal its diagnostic performance at ACMG annual meeting 2022 2022-03-21 22:00
ABclonal Technology Joins YCharOS Industry Advisory Committee to Tackle Reproducibility Crisis in Biomedical Research 2022-03-21 20:15
RNAGENE Signs a Collaborative Research Agreement with PharmAbcine to Develop Novel mRNA Therapeutics 2022-03-21 20:00
KAZIA TO PRESENT AT UPCOMING INVESTOR CONFERENCE AND AACR ANNUAL SCIENTIFIC MEETING 2022-03-21 20:00
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21 16:20
I-Mab to Report Full Year 2021 Financial Results and Provide Corporate Update on March 29, 2022 2022-03-18 20:00
China CDE Approved First Universal CAR-T IND ! 2022-03-17 21:32
Triastek and Siemens announce strategic collaboration to accelerate digital transformation of the pharmaceutical industry 2022-03-17 21:24
1 135 136 137 138 139 432